Enanta Pharmaceuticals Inc (ENTA) — Cash Flow Quality Index
Enanta Pharmaceuticals Inc (ENTA) has a Cash Flow Quality Index of 0.92x as of December 2019. Operating cash flow of $12.36 Million is below net income of $13.44 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Enanta Pharmaceuticals Inc cash conversion from operations to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Enanta Pharmaceuticals Inc Cash Flow Quality Index (2010–2019)
Historical Cash Flow Quality Index for Enanta Pharmaceuticals Inc across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ENTA cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Enanta Pharmaceuticals Inc (2010–2019)
Year-by-year earnings quality comparison for Enanta Pharmaceuticals Inc. For live market cap and the full company financial profile, see ENTA stock market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 1.54x | $71.42 Million | $46.38 Million | ▲ +279.2% |
| 2018 | 0.41x | $29.22 Million | $71.96 Million | ▼ -86.3% |
| 2017 | 2.97x | $52.65 Million | $17.71 Million | ▲ +79.9% |
| 2016 | 1.65x | $35.81 Million | $21.67 Million | ▲ +70.3% |
| 2015 | 0.97x | $76.67 Million | $78.99 Million | ▲ +65.7% |
| 2014 | 0.59x | $20.18 Million | $34.44 Million | ▼ -47.0% |
| 2013 | 1.11x | $10.65 Million | $9.63 Million | ▲ +4.7% |
| 2012 | 1.06x | $22.62 Million | $21.40 Million | ▲ +2.6% |
| 2011 | 1.03x | $24.02 Million | $23.31 Million | ▲ +180.0% |
| 2010 | -1.29x | $-10.18 Million | $7.90 Million | — |